← Back to guidelines
Endocrinology106 papers

Episode of harmful use of steroid hormone

Last edited: 4/15/2026

Overview

Episodes of harmful use of steroid hormones involve excessive and inappropriate use leading to significant adverse health outcomes, including hormonal imbalances and organ dysfunction 1.

Diagnosis

  • Clinical presentation includes symptoms related to hormonal excess or deficiency, such as Cushingoid features, adrenal insufficiency signs, or metabolic disturbances 1.
  • Laboratory tests: Elevated serum cortisol levels, abnormal diurnal cortisol rhythm, and assessment of steroid hormone receptor function (consider quality control measures in assays to ensure reliability) 2.
  • Imaging may be necessary to evaluate organ damage or complications 1.
  • Management

  • First-line treatments:
  • - Cessation of exogenous steroid administration. - Symptomatic management (e.g., fluid and electrolyte balance correction, treatment of infections) 1.
  • Adjunctive treatments:
  • - Glucocorticoid antagonists like mifepristone in severe cases (specific dosing not detailed in abstracts) 1. - Supportive care including psychological counseling to address underlying misuse behaviors 1.

    Special Populations

  • Pregnancy: Specific management strategies are not detailed in the provided abstracts 1.
  • Pediatrics: Growth and developmental impacts require careful monitoring and tailored interventions (details not provided) 1.
  • Elderly: Increased risk of complications necessitates cautious management with emphasis on geriatric assessments (specific guidance lacking) 1.
  • Comorbidities: Management must consider interactions with existing conditions; tailored approaches are advised but not explicitly detailed 1.
  • Key Recommendations

  • Implement rigorous quality control measures in steroid hormone receptor assays to ensure accurate diagnosis 2 (Evidence: Moderate).
  • Prioritize cessation of harmful steroid use and symptomatic management tailored to clinical presentation 1 (Evidence: Expert opinion).
  • Consider psychological support for patients to address underlying misuse behaviors 1 (Evidence: Expert opinion).
  • References

    1 Brown T. Aroused: A Rousing Look at Hormones. The American journal of nursing 2021. link 2 Smith RG. Quality control in steroid hormone receptor assays. Cancer 1980. link46:12+<2946::aid-cncr2820461441>3.0.co;2-a)

    Original source

    1. [1]
      Aroused: A Rousing Look at Hormones.Brown T The American journal of nursing (2021)
    2. [2]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG